2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in Sweden Leader Award
2022 - Research.com Neuroscience in Sweden Leader Award
1989 - Member of Academia Europaea
His primary scientific interests are in Internal medicine, Endocrinology, Dopamine, Neuroscience and Receptor. His study in Catecholamine, Hypothalamus, Tyrosine hydroxylase, Apomorphine and Medulla oblongata falls under the purview of Internal medicine. His Endocrinology research incorporates elements of Agonist, Neuropeptide Y receptor and Spinal cord.
He has included themes like Monoamine neurotransmitter, Stimulation and Pharmacology in his Dopamine study. Kjell Fuxe combines subjects such as Neurotransmission and Anatomy with his study of Neuroscience. His Dopamine receptor D2 research includes themes of Adenosine, Biophysics, Adenosine A2A receptor, Cell biology and Dopamine receptor.
Kjell Fuxe mainly focuses on Internal medicine, Endocrinology, Dopamine, Neuroscience and Receptor. His Endocrinology research incorporates themes from Agonist and Neuropeptide Y receptor. His research on Dopamine often connects related areas such as Pharmacology.
His research in Neuroscience intersects with topics in Glutamate receptor, Monoamine neurotransmitter, Neurotransmission and Heteroreceptor. The Receptor study combines topics in areas such as Biophysics and Cell biology. Kjell Fuxe has researched Dopamine receptor D2 in several fields, including Adenosine A2A receptor and Adenosine.
Kjell Fuxe mostly deals with Neuroscience, Receptor, Internal medicine, Endocrinology and Heteroreceptor. His study looks at the relationship between Neuroscience and fields such as Glutamate receptor, as well as how they intersect with chemical problems. His Receptor study incorporates themes from Adenosine and Pharmacology.
He interconnects Raphe and Proximity ligation assay in the investigation of issues within Heteroreceptor. His G protein-coupled receptor research includes elements of Biophysics and Allosteric regulation. His Dopamine receptor D2 research is under the purview of Dopamine.
Kjell Fuxe spends much of his time researching Neuroscience, Receptor, Dopamine, G protein-coupled receptor and Pharmacology. His Neuroscience research includes themes of Glutamate receptor, Metabotropic glutamate receptor 5, Neurotransmission and Heteroreceptor. His study looks at the intersection of Receptor and topics like Drug development with Drug discovery.
Endocrinology and Internal medicine are the focus of his Dopamine studies. His research investigates the link between Endocrinology and topics such as Receptor antagonist that cross with problems in Competitive antagonist. His research integrates issues of Agonist, Dopamine receptor D1, Psychiatry and Monoamine neurotransmitter in his study of Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.
A Dahlstroem;K Fuxe.
Acta Physiologica Scandinavica (1964)
EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. 3. THE MONOAMINE NERVE TERMINAL.
Kjell Fuxe.
Cell and Tissue Research (1965)
Ascending Monoamine Neurons to the Telencephalon and Diencephalon
N.‐E. Andén;A. Dahlström;K. Fuxe;K. Larsson.
Acta Physiologica Scandinavica (1966)
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
Nils-Erik Andén;Sherrel G. Butcher;Hans Corrodi;Kjell Fuxe.
European Journal of Pharmacology (1970)
Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine
Marina R. Picciotto;Marina R. Picciotto;Michele Zoli;Roberto Rimondini;Clément Léna.
Nature (1998)
EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. II. EXPERIMENTALLY INDUCED CHANGES IN THE INTRANEURONAL AMINE LEVELS OF BULBOSPINAL NEURON SYSTEMS.
Dahlstroem A;Fuxe K.
Acta Physiologica Scandinavica (1965)
Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain
T. Ho¨kfelt;K. Fuxe;M. Goldstein;O. Johansson.
Brain Research (1974)
Demonstration and mapping out of nigro-neostriatal dopamine neurons
N.-E. Andén;A. Carlsson;A. Dahlström;K. Fuxe.
Life Sciences (1964)
Evidence for dopamine receptor stimulation by apomorphine
Nils-Erik Andén;Allan Rubenson;Kjell Fuxe;Tomas Hökfelt.
Journal of Pharmacy and Pharmacology (2011)
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Sergi Ferré;Kjell Fuxe;Bertil B. Fredholm;Micaela Morelli.
Trends in Neurosciences (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Karolinska Institute
New York University
Karolinska Institute
University of Modena and Reggio Emilia
Karolinska Institute
National Institute on Drug Abuse
University of Ferrara
University of Ferrara
Karolinska Institute
University of Barcelona
University of Cincinnati
Council of Scientific and Industrial Research
Queen's University
Babraham Institute
University of Lorraine
McGill University
University of Tokyo
Memorial Sloan Kettering Cancer Center
University of Washington
Umeå University
Aix-Marseille University
SUNY Downstate Medical Center
Monash University
University of California, San Diego
Yonsei University
University of Queensland